GOVO Venture Partners Invests in Medzown
Winter Park, Florida - GOVO Venture Partners made its fifth portfolio company investment since announcing the launch of its venture fund, GOVO Fund I, in January 2023. The investment is part of a $3 million seed round for Medzown, Inc.
Medzown, based in Palm Gardens, Florida is revolutionizing how patients with cancer and complex and rare diseases get timely access to cutting-edge treatments. To do this, the company applies advanced analytics and deep expertise to bridge the gap between patients and treatments like immunotherapies, targeted therapies, cell and gene therapies, and clinical trials.
Medzown’s solution provides patients and their care team with information and strategies to evaluate treatment options including clinical trials. The solution benefits employers and payers by reducing waste and overall cost of care.
Rob Panepinto, GOVO’s managing general partner, said of the investment, “With an estimated $1 trillion required to treat complex and rare diseases alone by 2030, GOVO sees Medzown’s application of precision medicine management to a fragmented healthcare system as a significant value proposition. By guiding patients to the right treatments and clinical trials, patient care can be greatly improved while also driving efficiency for pharmaceutical companies, employers, and payers. The company’s leadership are experienced medical and health insurance experts who understand exactly where its solution fits in the market.” Panepinto will be joining the board of Medzown.
Jennifer Levin Carter, MD, MPH, MBA, founder and Chief Executive Officer of Medzown, said, “We are very excited to partner with GOVO. GOVO brings deep, strategic expertise that will be very valuable to Medzown. They are focused on working with entrepreneurs and early-stage, high-impact companies to support rapid growth. We are seeing incredible interest in the Medzown solution. Rob and his colleagues at GOVO will be great partners as we scale the delivery of precision medicine.
ABOUT GOVO VENTURE PARTNERS
GOVO Venture Partners is a Winter Park, Florida-based company. GOVO Fund I is a venture fund that invests, seed round through series A, in early-stage companies for which doing business with government or navigating government regulations is an important success factor.
ABOUT MEDZOWN, INC.
Medzown is a leader in precision medicine management. With its proprietary technologies and expertise, Medzown aligns payer and pharmaceutical industry incentives around patients who are diagnosed with complex oncology, rare diseases, and other complex diseases.
For more information visit Medzown.com or contact hello@medzown.com.